197 related articles for article (PubMed ID: 10990520)
1. Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism.
Costa-Mallen P; Costa LG; Smith-Weller T; Franklin GM; Swanson PD; Checkoway H
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):535-7. PubMed ID: 10990520
[TBL] [Abstract][Full Text] [Related]
2. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
Costa-Mallen P; Costa LG; Checkoway H
Neurosci Lett; 2005 Sep; 385(2):158-62. PubMed ID: 15955630
[TBL] [Abstract][Full Text] [Related]
3. Gender difference in the interaction of smoking and monoamine oxidase B intron 13 genotype in Parkinson's disease.
Kelada SN; Costa-Mallen P; Costa LG; Smith-Weller T; Franklin GM; Swanson PD; Longstreth WT; Checkoway H
Neurotoxicology; 2002 Oct; 23(4-5):515-9. PubMed ID: 12428723
[TBL] [Abstract][Full Text] [Related]
4. The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smoking on Parkinson's disease.
Costa-Mallen P; Checkoway H; Fishel M; Cohen AW; Smith-Weller T; Franklin GM; Swanson PD; Costa LG
Neurosci Lett; 2000 Jan; 278(1-2):33-6. PubMed ID: 10643794
[TBL] [Abstract][Full Text] [Related]
5. The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease.
Oliveri RL; Annesi G; Zappia M; Civitelli D; De Marco EV; Pasqua AA; Annesi F; Spadafora P; Gambardella A; Nicoletti G; Branca D; Caracciolo M; Aguglia U; Quattrone A
Mov Disord; 2000 Jan; 15(1):127-31. PubMed ID: 10634251
[TBL] [Abstract][Full Text] [Related]
6. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease.
Löhle M; Mangone G; Wolz M; Beuthien-Baumann B; Oehme L; van den Hoff J; Kotzerke J; Reichmann H; Corvol JC; Storch A
Mov Disord; 2018 Sep; 33(9):1496-1501. PubMed ID: 30216543
[TBL] [Abstract][Full Text] [Related]
7. A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease.
Checkoway H; Franklin GM; Costa-Mallen P; Smith-Weller T; Dilley J; Swanson PD; Costa LG
Neurology; 1998 May; 50(5):1458-61. PubMed ID: 9596006
[TBL] [Abstract][Full Text] [Related]
8. Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population.
Sieminska A; Buczkowski K; Jassem E; Niedoszytko M; Tkacz E
BMC Med Genet; 2009 Sep; 10():92. PubMed ID: 19761593
[TBL] [Abstract][Full Text] [Related]
9. Possible interaction between MAOA and DRD2 genes associated with antisocial alcoholism among Han Chinese men in Taiwan.
Wang TJ; Huang SY; Lin WW; Lo HY; Wu PL; Wang YS; Wu YS; Ko HC; Shih JC; Lu RB
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):108-14. PubMed ID: 17007976
[TBL] [Abstract][Full Text] [Related]
10. Effects of Interaction Between Dopamine D2 Receptor and Monoamine Oxidase A Genes on Smoking Status in Young Men.
Huang CL; Ou WC; Chen PL; Liu CN; Chen MC; Lu CC; Chen YC; Lin MH; Huang CS
Biol Res Nurs; 2015 Jul; 17(4):422-8. PubMed ID: 26015071
[TBL] [Abstract][Full Text] [Related]
11. The DRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease.
Paus S; Grünewald A; Klein C; Knapp M; Zimprich A; Janetzky B; Möller JC; Klockgether T; Wüllner U
Mov Disord; 2008 Mar; 23(4):599-602. PubMed ID: 18175338
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.
Kiyohara C; Miyake Y; Koyanagi M; Fujimoto T; Shirasawa S; Tanaka K; Fukushima W; Sasaki S; Tsuboi Y; Yamada T; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
BMC Neurol; 2011 Jul; 11():89. PubMed ID: 21781348
[TBL] [Abstract][Full Text] [Related]
13. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects.
Kumudini N; Umai A; Devi YP; Naushad SM; Mridula R; Borgohain R; Kutala VK
Indian J Biochem Biophys; 2013 Oct; 50(5):436-41. PubMed ID: 24772965
[TBL] [Abstract][Full Text] [Related]
14. Monoamine oxidase B polymorphism, cigarette smoking and risk of Parkinson's disease: a study in an Asian population.
Tan EK; Chai A; Lum SY; Shen H; Tan C; Teoh ML; Yih Y; Wong MC; Zhao Y
Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):58-62. PubMed ID: 12815741
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease.
Tan EK; Tan Y; Chai A; Tan C; Shen H; Lum SY; Fook-Cheong SM; Teoh ML; Yih Y; Wong MC; Zhao Y
Mov Disord; 2003 May; 18(5):593-5. PubMed ID: 12722176
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele.
Planté-Bordeneuve V; Taussig D; Thomas F; Said G; Wood NW; Marsden CD; Harding AE
Neurology; 1997 Jun; 48(6):1589-93. PubMed ID: 9191771
[TBL] [Abstract][Full Text] [Related]
17. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.
McGuire V; Van Den Eeden SK; Tanner CM; Kamel F; Umbach DM; Marder K; Mayeux R; Ritz B; Ross GW; Petrovitch H; Topol B; Popat RA; Costello S; Manthripragada AD; Southwick A; Myers RM; Nelson LM
J Neurol Sci; 2011 Aug; 307(1-2):22-9. PubMed ID: 21663922
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
Masellis M; Collinson S; Freeman N; Tampakeras M; Levy J; Tchelet A; Eyal E; Berkovich E; Eliaz RE; Abler V; Grossman I; Fitzer-Attas C; Tiwari A; Hayden MR; Kennedy JL; Lang AE; Knight J;
Brain; 2016 Jul; 139(Pt 7):2050-62. PubMed ID: 27190009
[TBL] [Abstract][Full Text] [Related]
19. Dopamine receptor D2 intronic polymorphism in patients with Parkinson's disease.
Pastor P; Muñoz E; Obach V; Martí MJ; Blesa R; Oliva R; Tolosa E
Neurosci Lett; 1999 Oct; 273(3):151-4. PubMed ID: 10515181
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder.
Pivac N; Knezevic J; Kozaric-Kovacic D; Dezeljin M; Mustapic M; Rak D; Matijevic T; Pavelic J; Muck-Seler D
J Affect Disord; 2007 Nov; 103(1-3):131-8. PubMed ID: 17289152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
